ClinConnect ClinConnect Logo
Search / Trial NCT06950957

Video Laryngeal Mask vs. Endotracheal Tube in Septoplasty

Launched by SAMSUN UNIVERSITY · Apr 27, 2025

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

Septoplasty Laryngeal Mask Airway Endotracheal Tube Postoperative Sore Throat Airway Leak Otorhinolaryngology Surgery Supraglottic Airway Devices Aldrete Score Postoperative Sore Throat (Post Score)

ClinConnect Summary

This clinical trial is studying two different airway devices used during septoplasty, which is a surgery to correct a deviated septum in the nose. The researchers want to find out whether a video laryngeal mask airway (VLMA) or an endotracheal tube (ETT) is better at preventing blood contamination during surgery. They will also look at how well each device helps with breathing, the stability of patients' vital signs during the procedure, and how patients feel afterward, including any sore throat or hoarseness. The goal is to find the best option for patients undergoing this type of surgery.

To participate in this trial, you need to be an adult between 18 and 65 years old and classified as ASA I or II, meaning you are generally healthy or have mild health issues. Unfortunately, if you have certain conditions like a difficult airway, a high body mass index, or if you're pregnant, you won’t be eligible. Participants can expect to be part of a study that may help improve care for future patients undergoing nasal surgeries, and they will be closely monitored throughout the process for their comfort and safety. The trial is not yet recruiting participants, so there’s still time to think about whether this is something you’d like to consider.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ASA I-II classification patients
  • Patients aged 18-65 years undergoing elective septoplasty
  • Exclusion Criteria:
  • ASA III-IV classification patients
  • Patients with anticipated difficult airway
  • Patients under 18 years of age
  • History of gastroesophageal reflux disease (GERD) or hiatal hernia
  • Body mass index (BMI) \>30
  • Pregnant patients

About Samsun University

Samsun University is a leading academic institution dedicated to advancing medical research and clinical innovation. Committed to improving healthcare outcomes, the university sponsors a range of clinical trials that focus on diverse therapeutic areas. With a robust infrastructure and a team of experienced researchers, Samsun University fosters collaboration between multidisciplinary experts to ensure the highest standards of scientific rigor and ethical compliance. By integrating cutting-edge technology and evidence-based practices, the university aims to contribute valuable insights to the medical community and enhance patient care through its clinical research initiatives.

Locations

Samsun, Ilkadim, Turkey

Patients applied

0 patients applied

Trial Officials

Hatice Selcuk KUSDERCI, M.D.

Study Director

Samsun University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported